7 Cardiology Headlines You Missed in April 2026

Despite a relatively quiet month from the US Food and Drug Administration (FDA), the American College of Cardiology (ACC) Scientific Sessions 2026 more than made up for the lack of regulatory news with a continued series of key trial updates. From obstructive hypertrophic cardiomyopathy (oHCM) to hypercholesterolemia, all aspects of cardiology saw significant forward movement during this conference. Additionally, updates to the ABCs of Cardiology and other guidelines in April continued the paradigm shift towards prevention that cardiology has embraced in recent months.